// App-Quantinova.ai

POS22 : The prognostic value of high-sensitive C-Reactive protein in patients with coronary artery ectasia

Researchers

Presenter

  • Wang Y.T

Principal Investigators

  • Song W.H

Medical Centers

  • State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Centre for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Coronary artery ectasia

  • Myocardial infarction

Biomarkers

  • High sensitivity C-reactive protein

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved